To ascertain the clinical relevance of the iTRAQ results, the DEPs S100A8 and LRG1 were selected for further validation with sandwich ELISA in the individual serum specimens of 44 controls, 20 B-NHL patients and 20 T-NHL patients. The gene discussed is LRG1; the disease is non-Hodgkin lymphoma.